Vincent Keereman

[Molecubes @molecubes]

Dynamic PET studies with low injected activities or isotopes having a short half life? No problem for our beta-CUBE! See the result of experimenting with different acquisition times in the study featured below. #preclinicalimaging #lowactivityPET

[UAntwerpen @UAntwerpen]

Spin-off @E_p_i_l_o_g en #UAntwerpen slaan handen in elkaar en werken aan biomarkers in strijd tegen alzheimer.
https://t.co/rWI7ue3SRS

[Molecubes @molecubes]

All set for the opening reception. #SNMMI17 #preclinicalimaging

[Molecubes @molecubes]

Still a few days left to visit us at the Turku PET symposium. We'll be happy to show you our latest applications!

[Vincent Keereman @VincentKeereman]

en nu is de drank op #wtf #massiveattack

[Vincent Keereman @VincentKeereman]

please turn off the streetlights #massiveattack

[Vincent Keereman @VincentKeereman]

zalige beats maar hoe slecht georganiseerd #massiveattack @GREENHOUSE_TLNT

[Vincent Keereman @VincentKeereman]

The right way of looking at fundraising for startups https://t.co/MEw8ltbjON

[TechCrunch @TechCrunch]

All your questions about startup fundraising for KPCB… Asked and answered. https://t.co/tNTXfJycvt